26Fe The Use of Iron-Based Drugs in Medicine

Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine

Volumn , Issue , 2005, Pages 179-200

  Wu, Xiang ^a   Go, Mei Lin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

'veritable pills of Blaud'; Chloroquine resistant strains; Ferrocene ellagitannins; Ferrocene phenyl alkyl substitution; Ferrochloroquine; Inert hydrophobic spacer; Iron containing chalybeate waters; Metallic iron; Organometallics as drug candidates; TMH ferrocene

Indexed keywords

EID: 84889485016     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470864052.ch10     Document Type: Chapter

References (57)

1. E.M.E. Poskitt, Br. J. Haemotol., 122, 554-562 (2003).
2. P. Blaud, Revue Medicale Francaise Etrangere., 45, 341-367 (1832).
3. J. Thomson and L. Findlay, The Chemical Study of Treatment of Sick Children, Oliver & Boyd, Edinburgh, 1933.
4. H.M.M. Makay, Arch. Dis. Childhood, 3, 116-144 (1928).
5. H.M.M. Makay, MRC Special Report No. 157, HMSO, London, 1931.
6. L. Hallberg, Iron, in Human Nutrition and Dietetics, J.S. Garrow, W.P.I. James and A. Ralph (Eds), Churchill-Livingston, Edinburgh (2000).
7. R.S. Hillman, Hematopoietic agents, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird and A. Goodman Gilman (Eds), McGraw-Hill, New York (2001).
8. C. Hansch and A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology, John Wiley & Sons, New York (1979).
9. S. Venkatesh and R.A. Lipper, J. Pharm. Sci., 89, 145-154 (2000).
10. R.A. Yeary, Toxicol. Appl. Pharmacol., 15, 666-676 (1969).
11. H.W. Leung, D.W. Hallesy, L.D. Shott et al., Toxicol. Lett., 38, 103-108 (1987).
12. K.J. Nikula, J.D. Sun, E.B. Barr et al., Fund. Appl. Toxicol., 21, 127-139 (1993).
13. B. Halliwell and J.M.C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York (1999).
14. R.P. Hanzlik and W.H. Soine, J. Am. Chem. Soc., 100, 1290-1291 (1978).
15. P. Nielsen and H.C. Heinrich, Biochem. Pharmacol., 45, 385-391 (1993).
16. J.W. Halliday and J. Searle, Biometals, 9, 205-209 (1996).
17. E.E. Cable, J.R. Connor and H.C. Isom, Am. J. Pathol., 152, 781-792 (1998).
18. E.E. Cable and H.C. Isom, Drug Metab. Dispos., 27, 255-260 (1999).
19. B.E. Maryanoff, S.L. Keeley and F.J. Persico, J. Med. Chem., 26, 226-229 (1983).
20. D. Scutaru, L. Tataru, I. Mazilu et al., J. Organomet. Chem., 401, 81-85 (1991).
21. D. Scutaru, I. Mazilu, L. Tataru et al., J. Organomet. Chem., 406, 183-187 (1991).
22. C. Biot, N. Francois, L. Maciejewski et al., Bioorg. Med. Chem. Lett., 10, 839-841 (2000).
23. M. Yuriko, E. Brummer and D.A. Stevens. Myopathology, 138, 29-35 (1997).
24. S. Top, J. Tang, A. Vessieres et al., Chem. Commun., 955-956 (1996).
25. G. Jaouen, S. Top, A. Vessieres et al., Sci. Paris, Ser. IIc, Chim., 3, 89-93 (2000).
26. S. Top, A. Vessieres, C. Cabestaing et al., J. Organomet. Chem., 637-639, 500-506 (2001).
27. E.W. Neuse, Macromol. Symposia, 172, 127-138 (2001).
28. P. Köpf-Maier, H. Kopf and E.W. Neuse, J. Cancer Res. Clin. Oncol., 108, 336-340 (1984).
29. C. Biot, G. Glorian, L.A. Maciejewski and J.S. Brocard, J. Med. Chem., 40, 3715-3718 (1997).
30. O. Domarle, G. Blampain, H. Aganiet et al., Antimicrob. Agents Chemother., 42, 540-544 (1998).
31. L. Delhaes, H. Abessolo, C. Biot et al., Parasitol. Res., 87, 239-244 (2001).
32. B. Pradines, T. Fusai, W. Daries et al., J. Antimicrob. Chemother., 48, 179-184 (2001).
33. C. Atteke, J.M.M. Ndong, A. Aubouy et al., J. Antimicrob. Chemother., 51, 1021-1024 (2003).
34. L. Delhaes, C. Biot, L. Berry et al., Chembiochem., 3, 418-423 (2002).
35. C. Biot, L. Delhaes, H. Abessolo et al., J. Organomet. Chem., 589, 59-65 (1999).
36. C. Biot, L. Delhaes, C.M. N'Diaye et al., Bioorg. Med. Chem., 7, 2834-2847 (1999).
37. P. Beagley, M.A.L. Blackie, K. Chibale et al., Dalton Trans., 3046-3051 (2003).
38. K. Chibale, J.R. Moss, M. Blackie et al., Tetrahedron Lett., 41, 6231-6235 (2000).
39. D. De, F.M. Krogstad, L.D. Byers and F.M. Krogstad, J. Med. Chem., 41, 4918-4926 (1998).
40. L. Tilley, P. Loria and M. Foley, Chloroquine and other quinoline antimalarials, In Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery, P.J. Rosenthal (Ed.), Humana Press, NJ (2001).
41. C. Biot, L. Delhaes, L.A. Maciejewski et al., Eur. J. Med. Chem., 35, 707-714 (2000).
42. L. Delhaes, C. Biot, L. Berry et al., Bioorg. Med. Chem., 8, 2739-2745 (2000).
43. X. Wu, P. Wilairat and M.L. Go, Bioorg. Med. Chem. Lett., 12, 2299-2302 (2002).
44. T. Itoh, S. Shirakami, N. Ishida et al., Bioorg.Med. Chem. Lett., 10, 1657-1659 (2000).
45. J. Howarth and K. Hanlon, Tetrahedron Lett., 42, 751-754 (2001).
46. C.X. Zhang and S.J. Lippard, Curr. Opin. Chem. Biol., 7, 481-489 (2003).
47. M. Wenzel, M. Schneider and E. Liss, Z. Naturforsch C., 34, 670-676 (1979).
48. M.T. Johnson, E. Kreft, D.D. N'Da et al., J. Inorg. Organo. Polym., 13, 255-267 (2003).
49. J.C. Swarts, D.M. Swarts, D.M. Maree et al., Anticancer Res., 21, 2033-2038 (2001).
50. N.G. Connely and W.E. Geiger, Chem. Rev., 96, 877-910 (1996).
51. G. Caldwell, M.G. Meirim, E.W. Neuse and C.E.J. Van Rensburg, Appl. Organomet. Chem., 12, 793-799 (1998).
52. J.C. Swarts, E.W. Nuese and G.J. Lambrecht, J. Inorg. Organo. Polym., 4, 143-153 (1994).
53. D. Osella, M. Ferrali, P. Zanello et al., Inorg. Chim. Acta, 306, 42-48 (2000).
54. G. Tabbi, C. Cassino, G. Cavigiolio et al., J. Med. Chem., 45, 5786-5796 (2002).
55. Y.N. Vashisht, G.D. Jayaraju and A.K. Kondapi, Arch. Biochem. Biophys., 376, 229-235 (2000).
56. C.W. Ong, J.Y. Jeng, S.S. Juang and C.F. Chen, Bioorg. Med. Chem. Lett., 2, 929-932 (1992).
57. R. Kovjazin, T. Eldar, M. Patya et al., FASEB J., 17, 467-469 (2003).